Key result
GLUCOSE algorithm linked to ~54% lower insulin dosing error vs clinicians after cardiac surgery.
Why the study?
Does a distributional reinforcement learning algorithm (GLUCOSE) improve insulin dosing accuracy and estimated glucose control compared to clinicians in patients after cardiac surgery?
Observational (n=6,797)
Yes
Does a distributional reinforcement learning algorithm (GLUCOSE) improve insulin dosing accuracy and estimated glucose control compared to clinicians in patients after cardiac surgery?
An offline reinforcement learning algorithm (GLUCOSE) can recommend safe, effective, and personalized insulin doses for patients in the ICU after cardiac surgery, outperforming standard clinician dosing.
Answers are grounded in this paper and cite their sources.
Does not yet support changing post-cardiac surgery insulin dosing; hypothesis-generating for RL algorithms and requires prospective RCTs.
This study introduces Glucose Level Understanding and Control Optimized for Safety and Efficacy (GLUCOSE), a distributional offline reinforcement learning algorithm for optimizing insulin dosing after cardiac surgery. Trained on 5228 patients, tested on 920, and externally validated on 649, GLUCOSE achieved a mean estimated reward of 0.0 [-0.07, 0.06] in internal testing and -0.63 [-0.74, -0.52] in external validation, outperforming clinician returns of -1.29 [-1.37, -1.20] and -1.02 [-1.16, -0.89]. In multi-phase human validation, GLUCOSE first showed a significantly lower mean absolute error (MAE) in insulin dosing, with 0.9 units MAE versus clinicians' 1.97 units (p < 0.001) in internal testing and 1.90 versus 2.24 units (p = 0.003) in external validation. The second and third phases found GLUCOSE's performance as comparable to or exceeding that of senior clinicians in MAE, safety, effectiveness, and acceptability. These findings suggest GLUCOSE as a robust tool for improving postoperative glucose management.
No takes yet. Share an insight, caveat, or question.
Desman et al. (2025) conducted an observational in Hyperglycemia after cardiac surgery (n=6,797). GLUCOSE reinforcement learning algorithm vs. Clinician-administered insulin was evaluated on Mean absolute error (MAE) in insulin dosing (internal testing) (p=<0.001). The GLUCOSE reinforcement learning algorithm significantly reduced the mean absolute error in insulin dosing compared to clinicians (0.9 vs 1.97 units, p<0.001) in patients after cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: